Announcements Trials

Browse Landscape

Status

Sponsor Class

OTHER 14 UNKNOWN 1 OTHER_GOV 1 NIH 1

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Hormone Receptor Positive Advanced Breast Cancer 1

Interventions

Capecitabine 15 Paclitaxel 13 S 1 (combination) 9 apatinib 8 Oxaliplatin 8 Carboplatin 8 Cisplatin 7 pyrotinib 6 Epirubicin 6 Docetaxel 6 sintilimab 5 camrelizumab 5 anlotinib 5 Radiotherapy 5 Drug Therapy 5 130-nm albumin-bound paclitaxel 5 nimotuzumab 4 nedaplatin 4 Vinorelbine 4 Temozolomide 4 Irinotecan 4 Fulvestrant 4 Etoposide 4 Bevacizumab 4 toripalimab 3 titanium silicide 3 exemestane 3 Trastuzumab 3 Radiotherapy, Intensity-Modulated 3 Radiosurgery 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × UNKNOWN × Aromatase Inhibitors × Clear all

NCT05000736 2022-04-29

CAPACITY

ChineseAMS

Hormone Receptor Positive Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡